Skip to content
Citation only via OpenAlex

The Neurobiology and Pharmacotherapy of Alzheimer's Disease

Olivier Félician, Thomas A. Sandson

Journal of Neuropsychiatry · 1999 · ▲ 61 citations

Abstract

Alzheimer's disease (AD), the most common cause of dementia, has become a major public health concern as our population ages. In recent years, AD has attracted the attention of a wide range of biological disciplines, and substantial progress has been made in understanding the mechanisms of neurodegeneration in AD. Four different genes have now been associated with AD and are providing insights into the pathogenesis of the disease. The roles of beta-amyloid, tau, hormonal changes, inflammation, and oxidative stress in the neurodegeneration of AD are also being delineated. Based on these discoveries, rational therapeutic strategies are developing rapidly. The authors review these and other recent advances in the neurobiology and pharmacotherapy of AD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1176/jnp.11.1.19
Canonical
link ↗
Fetched
2026-10-17 MST

Cite this

APA
Félician, O., &amp; Sandson, T.A. (1999). The Neurobiology and Pharmacotherapy of Alzheimer's Disease. <em>Journal of Neuropsychiatry</em>. https://doi.org/10.1176/jnp.11.1.19
Vancouver
Félician O, Sandson TA. The Neurobiology and Pharmacotherapy of Alzheimer's Disease. Journal of Neuropsychiatry. 1999. doi:10.1176/jnp.11.1.19.
BibTeX
@article{olivier1999TheNeu, title = {The Neurobiology and Pharmacotherapy of Alzheimer's Disease}, author = {Olivier Félician and Thomas A. Sandson}, journal = {Journal of Neuropsychiatry}, year = {1999}, doi = {10.1176/jnp.11.1.19}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings